Jiang W - Search Results

1

Feasibility and efficiency of double-agent versus single-agent concurrent chemoradiotherapy in patients with nasopharyngeal carcinoma.

Qin G, Rai R, Zhang R, Su Y, Zhang B, Pan Y, Xiong R, Xie Y, Yang H, Kong X, Luo Z, Ruan X, Mo Y, Aftab O, Shahisanjeev, Jazib, Jiang W. Qin G, et al. Among authors: jiang w. Oral Oncol. 2020 Jul;106:104704. doi: 10.1016/j.oraloncology.2020.104704. Epub 2020 Apr 21. Oral Oncol. 2020. PMID: 32330685

2

Matched analysis of induction chemotherapy plus chemoradiotherapy versus induction chemotherapy plus radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a multicenter study.

Zhang B, Hu Y, Xiong RH, Pan YF, Xu QL, Kong XY, Cai R, Chen QQ, Tang HY, Jiang W. Zhang B, et al. Among authors: jiang w. Oncotarget. 2017 Feb 21;8(8):14078-14088. doi: 10.18632/oncotarget.13285. Oncotarget. 2017. PMID: 27845907 Free PMC article.

3

Chemotherapy regimens containing taxanes or fluorouracil in nasopharyngeal carcinoma: Which better?

Mi JL, Zhang B, Pan YF, Su YX, Fan JF, Liao SF, Qin XL, Yao DC, Tang HY, Jiang W. Mi JL, et al. Among authors: jiang w. Oral Oncol. 2017 Nov;74:34-39. doi: 10.1016/j.oraloncology.2017.09.003. Oral Oncol. 2017. PMID: 29103749

4

Efficacy and safety of intensity-modulated radiotherapy alone versus intensity-modulated radiotherapy plus chemotherapy for treatment of intermediate-risk nasopharyngeal carcinoma.

Aftab O, Liao S, Zhang R, Tang N, Luo M, Zhang B, Shahi S, Rai R, Ali J, Jiang W. Aftab O, et al. Among authors: jiang w. Radiat Oncol. 2020 Mar 16;15(1):66. doi: 10.1186/s13014-020-01508-4. Radiat Oncol. 2020. PMID: 32178698 Free PMC article.

5

Prognostic value of the tumor volume reduction rate after neoadjuvant chemotherapy in patients with locoregional advanced nasopharyngeal carcinoma.

Yang H, Liu Y, Zhang R, Ye Y, Chen Q, Qin Q, Huang L, Li X, Cai R, Tang H, Jiang W. Yang H, et al. Among authors: jiang w. Oral Oncol. 2020 Nov;110:104897. doi: 10.1016/j.oraloncology.2020.104897. Epub 2020 Jul 14. Oral Oncol. 2020. PMID: 32679404

6

Impact of the weekday of the first intensity-modulated radiotherapy treatment on the survival outcomes of patients with nasopharyngeal carcinoma: A multicenter cohort study.

Mo Y, Zhang B, Pan Y, Qin Q, Ye Y, Li X, Huang L, Jiang W. Mo Y, et al. Among authors: jiang w. Oral Oncol. 2021 May;116:105258. doi: 10.1016/j.oraloncology.2021.105258. Epub 2021 Mar 9. Oral Oncol. 2021. PMID: 33706048

7

Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma : A matched-pair multicenter analysis of outcomes.

Dong YY, Xiang C, Lu JX, Su YX, Pan YF, Cai R, Zhang RJ, He ZK, Liu ML, Huang H, Bai X, Tang HY, Shi YH, Wang Y, Jiang W. Dong YY, et al. Among authors: jiang w. Strahlenther Onkol. 2016 Jun;192(6):394-402. doi: 10.1007/s00066-016-0970-3. Epub 2016 May 23. Strahlenther Onkol. 2016. PMID: 27215563 English.

8

Elective upper-neck versus whole-neck irradiation of the uninvolved neck in patients with nasopharyngeal carcinoma: an open-label, non-inferiority, multicentre, randomised phase 3 trial.

Tang LL, Huang CL, Zhang N, Jiang W, Wu YS, Huang SH, Mao YP, Liu Q, Li JB, Liang SQ, Qin GJ, Hu WH, Sun Y, Xie FY, Chen L, Zhou GQ, Ma J. Tang LL, et al. Among authors: jiang w. Lancet Oncol. 2022 Apr;23(4):479-490. doi: 10.1016/S1470-2045(22)00058-4. Epub 2022 Feb 28. Lancet Oncol. 2022. PMID: 35240053 Clinical Trial.

9

Candidate tumor suppressor ZNF154 suppresses invasion and metastasis in NPC by inhibiting the EMT via Wnt/β-catenin signalling.

Hu Y, Qi MF, Xu QL, Kong XY, Cai R, Chen QQ, Tang HY, Jiang W. Hu Y, et al. Among authors: jiang w. Oncotarget. 2017 Aug 24;8(49):85749-85758. doi: 10.18632/oncotarget.20479. eCollection 2017 Oct 17. Oncotarget. 2017. PMID: 29156753 Free PMC article.

10

Development and validation of a gene expression-based signature to predict distant metastasis in locoregionally advanced nasopharyngeal carcinoma: a retrospective, multicentre, cohort study.

Tang XR, Li YQ, Liang SB, Jiang W, Liu F, Ge WX, Tang LL, Mao YP, He QM, Yang XJ, Zhang Y, Wen X, Zhang J, Wang YQ, Zhang PP, Sun Y, Yun JP, Zeng J, Li L, Liu LZ, Liu N, Ma J. Tang XR, et al. Among authors: jiang w. Lancet Oncol. 2018 Mar;19(3):382-393. doi: 10.1016/S1470-2045(18)30080-9. Epub 2018 Feb 7. Lancet Oncol. 2018. PMID: 29428165

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

16,170 results

Search Page